ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVO Advanced Oncotherapy Plc

1.925
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Oncotherapy Plc LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.925 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -29.49M -0.0549 -0.35 10.32M
Advanced Oncotherapy Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker AVO. The last closing price for Advanced Oncotherapy was 1.93p. Over the last year, Advanced Oncotherapy shares have traded in a share price range of 1.875p to 8.50p.

Advanced Oncotherapy currently has 537,481,209 shares in issue. The market capitalisation of Advanced Oncotherapy is £10.32 million. Advanced Oncotherapy has a price to earnings ratio (PE ratio) of -0.35.

Advanced Oncotherapy Share Discussion Threads

Showing 2901 to 2922 of 5650 messages
Chat Pages: Latest  118  117  116  115  114  113  112  111  110  109  108  107  Older
DateSubjectAuthorDiscuss
06/11/2016
18:09
I read the Sunday Times report, and I didn't pick up as much negative vibes as Shareprophets seem to have. I wonder, are we comparing like-with-like here? Is the AVO system the same as the other five or so that are expected to come on stream in the next couple of years? I somehow got the impression that the AVO system was more advanced, unique in fact. Here is an extract from their web site:


In summary, key competitive advantages of LIGHT:
Lower cost: We estimate that the cost of a LIGHT facility will be in the region of US$40m vs. US$160-200m for those using cyclotrons or synchrotrons;
Precision: The beam energy from a LIGHT machine can be varied during therapy, allowing the beam to more accurately target cancer cells and spare healthy tissues;
Compact: LIGHT will be smaller and materially lighter than conventional proton therapy solutions, significantly reducing the size and construction cost of the facility required to house it;
Modular: LIGHT will be modular in nature providing healthcare operators greater freedom to customise their service to particular treatments ie, providing lower energy accelerators for eye, head or neck treatments, and having the flexibility to increase this to higher energies through the addition of other modules;
Lower shielding requirements: LIGHT will require less shielding than conventional proton therapy solutions.

Could someone with more technical knowledge than I have, please clarify whether the AVO system is more advanced, or the same as the others?

vatnabrekk
06/11/2016
13:26
Yep. And just to offset some of the ramping tripe on this thread ..
scantrader
06/11/2016
09:21
Article in Sunday Times today on Proton therapy. Worth a read as it sets out some of the landscape.
waterloo01
01/11/2016
22:28
It also wasn't like they were relying on funds from PI's.
£10M subscription - half bought by management and half by MK Trust
They said that more funds would be raised at a later date through banks - non dilutive to equity holders (or something)
The £4M Open Offer was just to make sure that current shareholders did not feel left out.

It was quite short notice too so possibly a shortage of available funds impacted the take-up.

glibgibon
01/11/2016
19:08
I don't think the 84% take up is a worry. It was to us P-Is and we worry too much about daily share price movements and the continuing negative trend. I'd say at least there is less that are likely to be dumped every time we move away from this share price point!
gerhart
01/11/2016
17:52
As I read the RNS they received acceptances for 84% of the shares offered. This does not seem to me to indicate over enthusiasm to accquire them, hence the fall in the share price today ? Or am I missing something ?
par555
01/11/2016
15:41
There seems to be considerably more buys than sells today, unless there is something else going on in the background, so perhaps the share price will take an upward path soon.
vatnabrekk
01/11/2016
09:22
Not a share for the faint hearted or the impatient.
daijavu
01/11/2016
08:46
was feeling a little left out at not having taken advantage of the open offer...guess I needn't have worried...8% drop in 40 minutes...ffs!
tia1617
01/11/2016
07:28
So everyone happy? Whatever you applied for in the OO will be met in full. Hope you didn't over apply.

See the have fessed up to Evans going (even though he must have resigned some time back as I pointed out from his own wiki profile). Excellent news they have appointed another job for the boys from CERN. I don't think they get it.

Next up. Tell shareholders what the new timeline is!

waterloo01
31/10/2016
09:42
I recall that at one time AVO were suggesting a year or so from starting to produce a machine to intalling it in a hospital or clinic. I assume that means that to produce eight machines a year they would expect to have several machines in various stages of manufacture at any one time.

I need to find where I read it.

daijavu
31/10/2016
09:17
This last month has seen a vote of confidence from Thales & total co-operation from De Walden & Harley st.

Correct to say no-one can see the future & timings, but with friends like this ....

haydock
31/10/2016
09:14
Eric Huber, Managing Director of Large Instruments activity at Thales, commented: "Wherever safety and security are critical, Thales delivers. We feel that our work on the LIGHT accelerator is a natural extension of our activities in high RF energy equipment and systems. We believe Advanced Oncotherapy's smarter proton therapy solution will create a more effective, targeted cancer treatment."
haydock
31/10/2016
09:02
Good news, but as always no details on timings. At some point soon they're going to have to issue a proper time line to commercialisation. I suspect it won't be pretty.
igbertsponk
30/10/2016
11:33
It's an easy mistake to make. I've made it myself. LSE is the London Stock Exchange.
daijavu
30/10/2016
10:51
There was nothing at all on the LSE website. The glitch was on the lse website.
daijavu
30/10/2016
08:15
There was a bit of excitement on the lse discussion board last night. The site was telling us that AVO shares seemed to have been suspended or de-listed. The statement is not there this morning. It appears to have been a false alarm caused by a glitch on the lse website. There was nothing about AVO shares being suspended or delisted on the London Stock Exchange website or on any other shares website apart from lse.

Apparently the same notice appeared on lse discussion boards relating to other companies at the same time as it appeared on the AVO discussion board. That probably caused a bit of excitement among the shareholders of those companies as well.

We will know for certain tomorrow.

daijavu
29/10/2016
12:36
I think I've traced it. AVO use a company based in North Yorkshire called Purple Creative to create their website. They, in turn, base their websites on the technology of a Californian Company called DotNetNuke (DNN). The logo belongs to DNN.

I seems as if someone is making creative use of shortcuts in setting up AVO's presentations.

daijavu
29/10/2016
10:53
The Xoft header is a curiosity. I checked out other AVO presentations. The header of the Beaufort AVO presentation refers to Cyan Holdings which is a company that produces smart meters for gas and electricity supplies.

The AVO presentations all include the same red and blue 'D' logo immediately in front of the name in the header. In the case of the Hardman AVO presentation, the name in the header after the red and blue 'D' logo is Microsoft. The answer to the question might therefore lie with the company that owns the logo.

Further research is needed. Would you like to take a look?

daijavu
29/10/2016
07:32
daijavu, cheers. Can't promise to keep posting as not a holder but having kept an eye on AVO for some time (as a fan of proton therapy) and as a recent shareholder took a closer look, sparked by the revelation (not announced by the company but by another poster) that the planning permission had been withdrawn back in January, now approved.

I hope my fears about what they are not saying are unfounded and the company will come out and say they have ANO route to market that doesn't rely on Harley Street being open, however, and I'm sure many will have had the same experience, especially with blue sky shares, it's a case of eyes wide open,if you care about your money.

If I were a holder I would draw some comfort that the directors have put their hands in their pockets in the placing (although one wonders if they had to in order to get it away given the terms of the previous financing) and the sector your'e investing has great potential. I hope AVO is one of the winners, but they don't help themselves by being less than open.

Edit: wanted to check some facts so looked at most recent (Oct) investor presentation). Any one know why it's header refers to another companies system? (The Xoft Axxent Electronic Brachytherapy System for Stage 1 and Early Stage 2 breast cancer).

waterloo01
29/10/2016
00:31
waterloo01. That £130 million is to be shared between at least 100 machines. Most of the money will go on software upgrades to existing machines so my guess is that they are only looking to buy a couple of new Photon therapy machines.I doubt if is intended for proton therapy machines. There is not enough cash in the pot, especially as they are talking in the plural. The money is to be spent over two years and I suspect that NHS requisitioning procedures are likely to prevent AVO being considered within that time frame.

I agree that AVO might be more forthcoming with information but how many companies are? Do they all tell their shareholders every little thing? I don't think they do.

I pay close attention to everything you say and I hope you will continue to post and point out any negatives you think of and, hopefully, positives as well. You make me question my assumptions and stop me being carried away with enthusiasm. Even when I decide that the point you are making is not enough to make me sell, it makes me take a closer look. I am grateful for that. A note of caution is always useful.

One thing I would agree with you on. If I was obeying the rules, I wouldn't touch AVO with a bargepole. It's a Story share. It's got no product, no income, no cashflow, no dividends, almost no sales and it's all jam tomorrow. TW is right. It's not worth looking at. But...? It's got one hell of a story and I've decided to stick with it. So has Howard de Walden.

daijavu
28/10/2016
19:49
In what have I been wrong? I'm pointing out what every rational investor is asking themselves, or should be.
waterloo01
Chat Pages: Latest  118  117  116  115  114  113  112  111  110  109  108  107  Older

Your Recent History

Delayed Upgrade Clock